➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Dow
Medtronic
Harvard Business School
Merck

Last Updated: October 17, 2021

DrugPatentWatch Database Preview

Patent: 10,478,497

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,478,497
Title:Combinations of inecalcitol with an anti-CD38 agent and their uses for treating cancer
Abstract: The present invention concerns combinations of inecalcitol with an anti-CD38 agent such as daratumumab, MOR 202 or isatuximab for the treatment of cancer, such as hematological malignancies by increasing or inducing the expression of CD-38 by inecalcitol.
Inventor(s): Benjamin; Susan (Chatillon, FR), Planquette; Cecile (Palaiseau, FR), Delansorne; Remi (Paris, FR)
Assignee: HYBRIGENICS S.A. (Paris, FR)
Application Number:15/655,394
Patent Claims:see list of patent claims

Details for Patent 10,478,497

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Sanof-aventis U.s. Llc SARCLISA isatuximab INJECTION, SOLUTION, CONCENTRATE 761113 2020-03-02 ⤷  Try it Free HYBRIGENICS S.A. (Paris, FR) 2039-12-05 search
Sanofi Aventis Us SARCLISA isatuximab-irfc INJECTABLE;INJECTION 761113 2020-03-02 ⤷  Try it Free HYBRIGENICS S.A. (Paris, FR) 2039-12-05 RX Orphan search
Janssen Biotech DARZALEX daratumumab INJECTABLE;INJECTION 761036 2015-11-16 ⤷  Try it Free HYBRIGENICS S.A. (Paris, FR) 2039-12-05 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
AstraZeneca
Mallinckrodt
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.